Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             30 results found
no title author magazine year volume issue page(s) type
1 Adjusting for patient differences in predicting hospital mortality for percutaneous coronary interventions in the Clinical Outcomes Assessment Program Maynard, Charles
2003
145 4 p. 658-664
7 p.
article
2 Angioplasty, inflammation, and antiplatelet agents Moliterno, David J.
2003
145 4 p. 563-566
4 p.
article
3 Anticoagulation in acute cardiac care in patients with chronic kidney disease Reddan, Donal
2003
145 4 p. 586-594
9 p.
article
4 Assessing quality and outcomes for percutaneous coronary intervention: Choosing statistical models, outcomes, time periods, and patient populations Hannan, Edward L.
2003
145 4 p. 571-574
4 p.
article
5 Comparison of a silicon carbide-coated stent versus a noncoated stent in human beings: The Tenax versus Nir Stent Study's long-term outcome Unverdorben, Martin
2003
145 4 p. E17-
1 p.
article
6 Coronary artery calcification in black women and white women Khurana, Charanjit
2003
145 4 p. 724-729
6 p.
article
7 Coronary calcium: Is racial profiling necessary? Redberg, Rita
2003
145 4 p. 579-581
3 p.
article
8 Cytokine response after percutaneous coronary intervention in stable angina: Effect of selective glycoprotein IIb/IIIa receptor antagonism Bonz, Andreas W.
2003
145 4 p. 693-699
7 p.
article
9 Design of the Genetics of Early Onset Cardiovascular Disease (GENECARD) study Hauser, Elizabeth R.
2003
145 4 p. 602-613
12 p.
article
10 Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: Results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study Hague, Wendy
2003
145 4 p. 643-651
9 p.
article
11 Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: The Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy Serebruany, Victor L.
2003
145 4 p. 636-642
7 p.
article
12 Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty Briguori, Carlo
2003
145 4 p. 700-707
8 p.
article
13 Endothelium-independent coronary microvascular function: All vessels are not created equally Hasdai, David
2003
145 4 p. 567-568
2 p.
article
14 Heart failure after myocardial infarction: Prevalence of preserved left ventricular systolic function in the community Hellermann, Jens P.
2003
145 4 p. 742-748
7 p.
article
15 Heart failure with preserved systolic function after myocardial infarction: A growing burden? Ghali, Jalal K.
2003
145 4 p. 575-578
4 p.
article
16 Heterogeneity of microvascular dysfunction in women with chest pain not attributable to coronary artery disease: Implications for clinical practice Marroquin, Oscar C.
2003
145 4 p. 628-635
8 p.
article
17 Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary percutaneous coronary intervention Brodie, Bruce R.
2003
145 4 p. 708-715
8 p.
article
18 Interatrial septal mobility predicts larger shunts across patent foramen ovales: An analysis with transmitral Doppler scanning Fox, Ervin R.
2003
145 4 p. 730-736
7 p.
article
19 Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation Stoddard, Marcus F.
2003
145 4 p. 676-682
7 p.
article
20 Left atrial thrombus, transient ischemic attack, and atrial fibrillation: Does left atrial thrombus predict? Does absence protect? Sheahan, Richard G.
2003
145 4 p. 582-585
4 p.
article
21 Lessons from the implantable atrial defibrillator Todd, Derick M.
2003
145 4 p. 569-570
2 p.
article
22 Limitations of current risk-adjustment models in the era of coronary stenting Kizer, Jorge R.
2003
145 4 p. 683-692
10 p.
article
23 Nickel release after implantation of the Amplatzer occluder Ries, Marcus W.
2003
145 4 p. 737-741
5 p.
article
24 Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: Are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study Cotter, Gad
2003
145 4 p. 622-627
6 p.
article
25 Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease Kleber, Franz-Xaver
2003
145 4 p. 614-621
8 p.
article
26 Smoking and health outcomes after percutaneous coronary intervention Haddock, C.Keith
2003
145 4 p. 652-657
6 p.
article
27 The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study: To what extent should the results be generalizable? Gerschutz, Gregory P.
2003
145 4 p. 595-601
7 p.
article
28 Usefulness of the pediatric electrocardiogram in detecting left ventricular hypertrophy: Results from the Prospective Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2 HIV) multicenter study Rivenes, Shannon M.
2003
145 4 p. 716-723
8 p.
article
29 Use patterns of low-molecular weight heparin and the impact on length of stay in patients hospitalized for atrial fibrillation Kim, Michael H.
2003
145 4 p. 665-669
5 p.
article
30 What characterizes episodes of atrial fibrillation requiring cardioversion? Experience from patients with an implantable atrial cardioverter Frykman, Viveka
2003
145 4 p. 670-675
6 p.
article
                             30 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands